Geisinger Health System’s ProvenRecovery program, a population health initiative to combat opioid use after surgery, reduced the length hospital stays, saved $1.5 million, and contributed to an 18% reduction in opioid use across the organization since its pilot launched in June 2017.
Despite facing potential lawsuits and political opposition, CMS finalized some of its most controversial proposals in the 2019 OPPS final rule by implementing several site-neutral payment policies and 340B drug payment reductions.
